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Background
Hypertension is associated with the development of
myocardial fibrosis with a subsequent increase in the myo-
cardial extracellular volume (ECV). T1 measurements pre
and post a contrast cardiac magnetic resonance (CMR)
study provide a robust non-invasive method for quantifi-
cation of the ECV. We aimed to determine whether the
CMR-derived ECV can differentiate healthy volunteers
from patients with systemic arterial hypertension.
Methods
We performed a CMR study including T1 measurements
in 145 patients with hypertension. CMR variables were
compared to a group of age-, gender-matched healthy
volunteers. Patients with hypertension were followed for
the development of adverse cardiovascular outcomes
(death, heart failure admission, and atrial fibrillation).
Values were compared to age- and gender-matched
controls.
Results
Study patients were 66% male with a median age of 58
years (range 36-85), had a BMI of 30±4 kg/m2, a left ven-
tricular (LV) end-diastolic volume of 155±35 ml, an LV
mass index of 68±20 gms/m2, and a LV ejection fraction
of 61±6%. In comparison to healthy controls, patients with
hypertension had elevated LV volumes, LV mass, and left
atrial volumes. The ECV was elevated in patients with
hypertension as compared to healthy controls (hyperten-
sion vs. healthy controls, 0.34±0.03 vs. 0.29±0.03,
p<0.001). In patients with hypertension, there was a posi-
tive association between the ECV and indexed left atrial
volume (r=0.46, p<0.01), and the LV mass index (r=0.45,
p<0.01) and a negative association between the ECV and
early mitral annular relaxation (E’, r=-0.55, p<0.001). The
ECV was similar in males and females with AH (0.34±0.03
vs. 0.33±0.03, p=0.18). During a median follow-up time of
18 months, there were 52 events. In univariable analysis,
the ECV (hazard ratio (HR) 1.35, 95% CI 1.21-1.51, chi-
squared 24.6, p<0.0001), indexed maximal LA volume (HR
1.02, 95% CI 1.00-1.03, chi-squared 4.71, p=0.03), and the
LV mass index (HR 1.02, 95% CI 1.00-1.03, chi-squared
5.25, p=0.02) provided the strongest association with the
adverse clinical events. In a multivariate model, the ECV
provided the strongest adjusted association with the com-
posite endpoint. Each 10% increase in the ECV was asso-
ciated with a 24% increased risk of adverse events.
Conclusions
In comparison to healthy volunteers, the ECV is increased
in patients with hypertension, and is associated with struc-
tural and functional abnormalities. In follow-up, the ECV
provided the strongest adjusted association with a compo-
site end-point of death, heart failure hospitalization and
late AF recurrence.
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Figure 1 Kaplan-Meier curve showing the event-free survival in patients separated according to the median ECV value of 0.34. Results were
compared using a Log-Rank test. Events were a composite of death, heart failure admission, or late recurrence of atrial fibrillation. Time is
recorded in months.
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